Cargando…
Aripiprazole: from pharmacological profile to clinical use
Clinical experience with aripiprazole has confirmed the effectiveness and the safety of this novel antipsychotic drug in patients with schizophrenia as well as for the treatment of mania in type I bipolar disorder. However the generalization of the results from clinical trials requires further effor...
Autores principales: | Di Sciascio, Guido, Riva, Marco Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610784/ https://www.ncbi.nlm.nih.gov/pubmed/26508859 http://dx.doi.org/10.2147/NDT.S88117 |
Ejemplares similares
-
TARC: Turkish aripiprazole consensus report- Aripiprazole use and
switching from other antipsychotics to aripiprazole- consensus recommendations
by a Turkish multidisciplinary panel
por: Veznedaroglu, Baybars, et al.
Publicado: (2018) -
Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents
por: Kirino, Eiji
Publicado: (2014) -
Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
por: Wang, Sheng-Min, et al.
Publicado: (2014) -
Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010) -
Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011)